Tag: Switzerland

Health Care Roundup: Market Talk
World

Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0650 GMT – Roche Holding’s third-quarter sales update was underwhelming and consensus earnings estimates still look high for both this year and next, Deutsche Bank Research analyst Emmanuel Papadakis says in a research note. There are few reasons to believe the Swiss pharmaceutical giant’s stock underperformance will reverse anytime soon and clinical-trial updates due in the near term look unlikely to change that, DB Research says. “Whilst the market reaction was somewhat severe, that reflects a red tape and the reality is that the guidance update—or rather, lack thereof—was unhelpful and the story remains in a tough spot from which it appears there are f...
Lonza CEO Announces Abrupt Departure
World

Lonza CEO Announces Abrupt Departure

Lonza’s shares fell almost 7% on news the CEO would depart at the end of September, which RBC described as unexpected and was unlikely to provide the market with confidence heading into next month’s capital-markets day.
Julius Baer (SWX: BAER) Profit Jumps as New Money Flows From Credit Suisse (CS)
Money

Julius Baer (SWX: BAER) Profit Jumps as New Money Flows From Credit Suisse (CS)

Julius Baer Group Ltd.’s profit jumped in the first half of 2023, aided by better-than-expected inflows of client funds amid the crisis surrounding local rival Credit Suisse. Net income in the period rose 18% to 532 million Swiss francs ($614 million), the bank said in a statement Monday. Clients added 7.1 billion francs in new money, more than the 6.2 billion francs analysts had estimated.